Protected PCI Programs: Training with the Impella 2.5™ Heart Pump

Training and education are key components of Protected PCI™ programs using the Impella 2.5™ heart pump.

Who Should Be Trained?

Successful Protected PCI programs aim to train everyone involved in the Protected PCI program and include:

• Cardiovascular surgery staff
• Perfusion staff
• Cardiovascular nurses and technologists from the cath lab who assist with the set-up and insertion of the Impella 2.5 device
• Critical care nurses who care for the patient, monitor the device, change tubing and troubleshoot alarms
• ICU staff who accommodate the acute needs of Protected PCI patients, troubleshoot alarms, titrate drips and fulfill charting requirements
• Pharmacists who develop heparin drip protocols for the Impella 2.5 device, provide dextrose solution to the cath lab and handle orders for pre- and post-procedure care
• Clinical Nurse Navigators who provide education and follow-up for patients
• Coding and billing for reimbursement codes for the insertion, care and removal of the Impella 2.5 device
• Clinical Nurse Educators who establish training and competency-based evaluation

What is Learned?

• The technical specifications, appropriate use and functionality of the Impella 2.5 catheter
• Set up, insertion and use of the Impella 2.5 device
• Management of the Impella 2.5 device
• Troubleshooting
• Protected PCI patient selection and management

What Training is Available?

Abiomed, Inc. offers a thorough Impella 2.5 training program for physicians and hospital staff that includes:

• General training on Impella 2.5 set-up and operation
• Onsite, hands-on training for small groups of physicians and staff to practice using the Impella 2.5 device
• Proctored case training facilitated by an Abiomed Clinical Specialist and conducted on site for physicians and staff during actual cases utilizing the Impella 2.5 device
• Clinical support and troubleshooting during actual cases utilizing the Impella 2.5 device
• Online testing focusing on placement of the Impella 2.5 device in the ventricle, care during use, and device removal techniques
• Quick skills videos
• Print and web-based educational materials including appropriate indications, contraindications and important safety information concerning the the Impella 2.5 device
• Education on device management
• Console simulator
• 24/7 clinical and technical support through an Emergency Clinical Support Hotline
• Physician certification
• Refresher training to maintain skills among physicians and staff
• Reimbursement hotline
• Business reviews

A multidisciplinary approach to Impella 2.5 training allows this device to be used in a variety of settings.  The Impella 2.5 team will be happy to help you customize your training program to suit your needs.
Next Steps:

1. Learn more about the use of Impella 2.5 for PCI
2. Learn more about educational events for the Impella and Protected PCI

PROTECTED PCI™ – INDICATION & SAFETY INFO.

INDICATION FOR USE
The Impella 2.5™ System is a temporary (≤ 6 hours) ventricular support device indicated for use during high risk percutaneous coronary interventions (PCI) performed in elective or urgent, hemodynamically stable patients with severe coronary artery disease and depressed left ventricular ejection fraction, when a heart team, including a cardiac surgeon, has determined high risk PCI is the appropriate therapeutic option. Use of the Impella 2.5 System in these patients may prevent hemodynamic instability, which can result from repeat episodes of reversible myocardial ischemia that occur during planned temporary coronary occlusions and may reduce peri- and post-procedural adverse events.

CONTRAINDICATIONS
In connection with the above indication, the Impella 2.5™ is contraindicated for use with patients experiencing any of the following conditions:

• Mural thrombus in the left ventricle
• Presence of a mechanical aortic valve or heart constrictive device
• Aortic valve stenosis/calcification (equivalent to an orifice area of 0.6 cm2 or less)
• Moderate to severe aortic insufficiency (echocardiographic assessment graded as ≥ +2)
• Severe peripheral arterial disease precluding placement of the Impella 2.5™ System

POTENTIAL ADVERSE EVENTS
Additionally, potential for the following risks has been found to exist with use of the Impella 2.5 in the above indication: Acute renal dysfunction; Aortic insufficiency; Aortic valve injury; Atrial fibrillation; Bleeding; Cardiogenic shock; Cardiac tamponade; Cardiopulmonary resuscitation; Cerebral vascular accident/Stroke; Death; Device malfunction; Failure to achieve angiographic success; Hemolysis; Hepatic failure; Insertion site infection; Limb ischemia; Myocardial infarction; Need for cardiac, thoracic or abdominal operation; Perforation; Renal failure; Repeat revascularization; Respiratory dysfunction; Sepsis; Severe hypotension; Thrombocytopenia; Thrombotic vascular (non-CNS) complication; Transient ischemic attack; Vascular injury; Ventricular arrhythmia, fibrillation or tachycardia.